Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS SA to Report First Quarter 2017 Financial Results on May 17, 2017
LYON, France , May 2, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2017 , after the close of the financial markets on May 17, 2017 .
View HTML
Toggle Summary EDAP Achieves 63% Growth in HIFU Revenue in 2016
2016 Highlights Total revenue for 2016 reached double-digit growth, increasing to EUR 35.6 million ( USD 39.3 million ) Gross margin for 2016 expanded to 46.1% compared to 42.8% during the prior year period Strong cash position of EUR 22.0 million ( USD 23.2 million ) as of December 31, 2016 LYON,
View HTML
Toggle Summary EDAP's Ablatherm® Robotic HIFU: Clinical Results Support High-Intensity Focused Ultrasound (HIFU) for Prostate Tissue Ablation after Unsuccessful Radiotherapy
Multicenter Retrospective Analysis of 418 Patients  LYON, France , March 22, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU for prostate tissue ablation in patients who
View HTML
Toggle Summary EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017
EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017 LYON, France , March 14, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,
View HTML
Toggle Summary EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation
EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation LYON, France, March 8, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that the prestigious Focused Ultrasound Foundation,
View HTML
Toggle Summary EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S.
EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S. LYON, France , March 6, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the appointment of Noah J. Bartsch as Vice President of Global Medical, Regulatory, and
View HTML
Toggle Summary EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota LYON, France , February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at the University of Minnesota , Minneapolis ,
View HTML
Toggle Summary EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately €35.6 million  2016 HIFU revenues recorded over 63% growth Strong cash position of €22 million Company to announce fourth quarter and full year 2016 results April 3rd with accompanying
View HTML
Toggle Summary EDAP to Exclusively Distribute LABORIE's Medical Measurement Systems Urodynamic Products in Japan
LYON, France , Jan. 23, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (NASDAQ:EDAP), the global leader in therapeutic ultrasound, announced today that it has signed an exclusive agreement with the Canadian company LABORIE to distribute their urodynamic diagnostic products in Japan , one of the largest
View HTML
Toggle Summary EDAP to Host Meetings with Investors During JP Morgan Healthcare Conference Week
LYON, France , Jan. 04, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will be hosting meetings with analysts and investors during the JP Morgan Healthcare conference week, January 9th & 10th in San Francisco, CA.
View HTML